7 results
  • carnexiv

    (Carbamazepine)
    Lundbeck Pharmaceuticals LLC
    CARNEXIV is indicated as replacement therapy for oral carbamazepine when oral administration is not feasible, applicable to adults with partial seizures (complex), generalized tonic-clonic seizures, and mixed seizure patterns. It is not suitable for absence seizures due to potential increased convulsion frequency.
  • northera

    (droxidopa)
    Lundbeck Pharmaceuticals LLC
    NORTHERA is indicated for treating orthostatic dizziness, lightheadedness, or pre-blackout sensations in adults with symptomatic neurogenic orthostatic hypotension caused by conditions like Parkinson's disease, multiple system atrophy, dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy. Effectiveness beyond two weeks is unestablished.
  • onfi

    (clobazam)
    Lundbeck Pharmaceuticals LLC
    ONFI (clobazam) is indicated as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome (LGS) in patients aged 2 years and older.
  • sabril

    (vigabatrin)
    Lundbeck Pharmaceuticals LLC
    SABRIL is indicated as adjunctive therapy for adults and children (2+) with refractory complex partial seizures and as monotherapy for infants (1 month to 2 years) with infantile spasms, provided the benefits outweigh the risk of vision loss. It is not a first-line treatment for complex partial seizures.
  • sabril

    (vigabatrin)
    Lundbeck Pharmaceuticals LLC
    SABRIL is indicated as adjunctive therapy for adults and children (2 years and older) with refractory complex partial seizures and as monotherapy for infants (1 month to 2 years) with infantile spasms, where benefits outweigh the risk of vision loss. Not a first-line treatment for complex partial seizures.
  • vyepti

    (eptinezumab-jjmr)
    Lundbeck Pharmaceuticals LLC
    VYEPTI is indicated for the preventive treatment of migraine in adults.
  • xenazine

    (tetrabenazine)
    Lundbeck Pharmaceuticals LLC
    XENAZINE is indicated for treating chorea associated with Huntington's disease.